Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James McGrath
University of Rochester, Department: Biomedical Engineering
Should you be removed from our database? Contact us at [email protected]. Read more below.
SiMPore
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. McGrath is a shareholder in SiMPore and sits on its Board of Directors. SiMPore is a company commercializing the membrane technology for the separation and purification of biomolecules and other nano-sized particles in a wide range of applications. Dr. McGrath is also the PI on a NIH awards that uses the silicon membrane technology. Because of the overlapping aims, it has been determined that Dr. McGrath’s financial interest in SiMPore could directly and significantly affect the design, conduct and reporting of the award referenced above.
Solid-State Nanopores integrated with Nanoporous Membranes for enhanced Single-Molecule Counting of low-abundance Biomarkers
Narrative The speed and sensitivity of solid-state nanopores make them ideal candidates for the detection of low abundance biomarkers, however they currently operate below their potential due to low event rate and pore clogging issues. This project introduces novel technology that addresses both of these issues. The goal of the project is to demonstrate the use of the new technology to detect fM concentrations of biomarker in 10 ul of blood plasma in under 10 minutes.
Filed on June 21, 2017.
Tell us what you know about James McGrath's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
James McGrath filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| James McGrath | University of Rochester | Conflict of Interest | SiMPore | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.